- Self-care Solutions
Driving self-care access through Innovation and Medical Insights
Everyone deserves access to healthcare. There are many social determinants of health including location, income, education and job status. Human-centered innovation can improve health equity by understanding how all of these can impact health and developing medical insights to help create new self-care solutions.
Self-care Innovation to Address Social and Environmental Determinants of Health
Socio-economic factors can play an impactful role in our health and wellness, including affecting how genetic predispositions are expressed. This is especially true in low-income communities where often unexpected environmental factors can impact everything from allergies and pain to cardiovascular health.
To fuel our progress and uncover opportunities where we can intervene, we launched the Research Initiative for Self-Care Equity (RISE) to understand better the socioeconomic impacts of people's health and to use these insights to inform our roadmap for accessible self-care innovation.
Medical insight is at the heart of Bayer’s innovation cycle. All our everyday self-care products have a robust evidence base that demonstrates their biological safety and effectiveness.
Explore how Socio-economic Status* can impact your health
* Based on the insights from the Bayer Research Initiative for Self-Care Equity (RISE)
Through these insights, we can start to understand how environmental and socio-economic factors create and exacerbate health challenges and design everyday health innovations to address them.
The insights from RISE are just the start. As we seek to enable people to take more control of their personal health, uncovering the layers of this research is imperative. We look forward to strengthening health systems around the world, whether it’s by creating new solutions to meet their unique needs, making programs more affordable in underserved communities, or expanding health education.
Listening, Learning, Launching
Bayer China recently uncovered that 80% of upper GI sufferers experience indigestion and more than 90% of digestive enzyme treatments in China come from hospitals. Turning these insights into innovation, the team launched a new formulation of Talcid Digestive. This self-care innovation puts consumers’ health into their own hands to relieve lack of appetite and indigestion through patented double-coated pellets with four types of digestive enzymes.
Innovation Showcases
This site is intended to provide information to an international audience. Not all products discussed on this site may be available in your country, and local prescribing information and approved indications may differ from country to country.